Pair of R&D updates bolster GSK ahead of investor meeting

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares

ViiV’s Rukobia cleared in EU as rescue HIV therapy

The European Commission has given a green light to the use of ViiV Healthcare’s Rukobia as a treatment for people with HIV that has developed resistance to other antiretroviral therapy (ART

ViiV launches digital triage service for HIV patients with L...

ViiV Healthcare and London’s Westminster Hospital NHS Foundation Trust have launched a digital triage service for HIV patients supported by a mobile app.

ViiV gets FDA nod for Rukobia drug for older HIV patients

The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is sta

ViiV’s two-drug HIV therapy Dovato gets Japanese approval

ViiV files first-in-class HIV drug in Europe